Immunosuppressive effect of prolactin-induced protein: A new insight into its local and systemic role in chronic allergic contact dermatitis

British Journal of Dermatology

Volumn 162, Issue 6, 2010, Pages 1286-1293

  Sugiura, S ^a   Fujimiya, M ^b   Ebise, H ^c   Miyahira, Y ^d   Kato, I ^e   Sugiura, Y ^f   Kimura, T ^c   Uehara, M ^g   Sato, H ^h   Sugiura, H ^h,i  

^a KYOTO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

^e HOKURIKU UNIVERSITY   (Japan)

^f NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^g Yasu Hospital   (Japan)

^h SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁱ Sugiura Skin Clinic   (Japan)

Author keywords

Atopic dermatitis; Chronic contact dermatitis; Prolactin induced protein; Tolerance

Indexed keywords

ACTIN BINDING PROTEIN; OXAZOLONE; PROLACTIN; PROLACTIN INDUCED PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CHRONIC DISEASE; CONTACT SENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KERATINOCYTE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OTITIS; PARAKERATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN ALLERGY; SPLEEN;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ANIMALS; CARRIER PROTEINS; CHRONIC DISEASE; DERMATITIS, ALLERGIC CONTACT; DISEASE MODELS, ANIMAL; EAR; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MICE; OXAZOLONE; SKIN; SPLEEN;

EID: 77952729449     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09756.x     Document Type: Article

References (21)

1. Yu-Lee LY. Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 2002 57 : 435 455.
2. Murphy LC, Tsuyuki D, Myal Y, Shiu RPC. Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). J Biol Chem 1987 262 : 15236 15241.
3. Gaubin M, Autiero M, Basmaciogullari S et al. Potent inhibition of CD4/TCR-mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells. J Immunol 1999 162 : 2631 2638.
4. Haagensen DE Jr., Gall SA, Brazy JE et al. Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein. Am J Obstet Gynecol 1980 138 : 25 32.
5. Sánchez LM, Vizoso F, Díez-Itza I et al. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res 1992 52 : 95 100.
6. Autiero M, Abrescia P, Guardiola J. Interaction of seminal plasma proteins with cell surface antigens: Presence of a CD4-binding glycoprotein in human seminal plasma. Exp Cell Res 1991 197 : 268 271.
7. Autiero M, Houlgatte R, Martin M et al. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4. Int Immunol 1995 7 : 191 197.
8. Basmaciogullari S, Autiero M, Culerrier R et al. Mapping the CD4 binding domain of gp17, a glycoprotein secreted from seminal vesicles and breast carcinomas. Biochemistry 2000 39 : 5332 5340.
9. Lynch GW, Slaytor EK, Elliott FD et al. CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers. Exp Dermatol 2003 12 : 700 711.
10. Albanesi C, Cavani A, Girolomoni G. Interferon-γ-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules. J Invest Dermatol 1998 110 : 138 142.
11. Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ 2006 332 : 584 588.
12. Sugiura H, Uchiyama M, Omoto M et al. Prevalence of infantile and early childhood eczema in a Japanese population: comparison with the disease frequency examined 20 years ago. Acta Derm Venereol (Stockh) 1997 77 : 52 3.
13. Sugiura H, Umemoto N, Deguchi H et al. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago. Acta Derm Venereol (Stockh) 1998 78 : 293 294.
14. Nagata K, Fujimiya M, Sugiura H, Uehara M. Intracellular localization of serotonin in mast cells of the colon in normal and colitis rats. Histochem J 2001 33 : 559 568.
15. Mizutani M, Atsuchi K, Asakawa A et al. Localization of acyl ghrelin- and des-acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric pH. Am J Physiol Gastrointest Liver Physiol 2009 297 : 974 980.
16. Myal Y, Iwasiow B, Yarmill A et al. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene. Endocrinology 1994 135 : 1605 1610.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 1995 57 : 289 300.
18. Lee B, Bowden GH, Myal Y. Identification of mouse submaxillary gland protein in mouse saliva and its binding to mouse oral bacteria. Arch Oral Biol 2002 47 : 327 332.
19. Caputo E, Manco G, Mandrich L et al. A novel aspartyl proteinase from apocrine epithelia and breast tumors. J Biol Chem 2000 275 : 7935 7941.
20. Schindler C. Cytokines and JAK-STAT signaling. Exp Cell Res 1999 253 : 7 14.
21. Carsol JL, Gingras S, Simard J. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: A unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor. Mol Endocrinol 2002 16 : 1696 1710.